Inactive Instrument
Argos Therapeutics Inc Stock Nasdaq
Stocks
US0402212023
Pharmaceuticals
OTC Markets Traded
| Market Cap | 318K 277K 256K 240K 450K 29.97M 453K 3.04M 1.18M 14.75M 1.19M 1.17M 51.22M | P/E 2016 |
-2.96x | P/E 2017 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 4.58M 4M 3.7M 3.47M 6.5M 433M 6.54M 43.92M 17.02M 213M 17.21M 16.84M 739M | EV / Sales 2016 |
200x | EV / Sales 2017 | 9.19x |
| Free-Float |
88.73% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | -4.99% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.99% | -75.88% | - | - | 567K | |
| +0.33% | -0.36% | +18.76% | -22.11% | 62.05B | |
| +0.20% | -9.17% | +58.39% | +196.56% | 54.52B | |
| -3.92% | +37.40% | +37.40% | +37.40% | 41.55B | |
| +7.62% | +8.19% | -51.27% | -59.11% | 39.06B | |
| -1.05% | -1.73% | +55.35% | -33.92% | 29.02B | |
| +3.50% | +28.15% | +151.81% | -50.31% | 25.38B | |
| -0.78% | -9.50% | +43.87% | +55.34% | 19.62B | |
| +1.74% | -0.39% | -2.93% | +113.90% | 16.89B | |
| -0.05% | +0.23% | +61.48% | +101.93% | 15.89B | |
| Average | +0.26% | +2.77% | +41.43% | +37.74% | 33.78B | |
| Weighted average by Cap. | +0.78% | +1.72% | +36.67% | +36.05% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 945K 824K 763K 715K 1.34M 89.21M 1.35M 9.06M 3.51M 43.91M 3.55M 3.47M 152M | 1.9M 1.66M 1.53M 1.44M 2.69M 179M 2.71M 18.2M 7.05M 88.22M 7.13M 6.98M 306M |
| Net income | -53.03M -46.24M -42.82M -40.09M -75.18M -5B -75.63M -508M -197M -2.46B -199M -195M -8.55B | -40.58M -35.38M -32.77M -30.67M -57.53M -3.83B -57.88M -389M -151M -1.88B -152M -149M -6.54B |
| Net Debt | -13.11M -11.43M -10.59M -9.91M -18.58M -1.24B -18.7M -126M -48.67M -609M -49.21M -48.15M -2.11B | 4.27M 3.72M 3.45M 3.23M 6.05M 403M 6.09M 40.88M 15.84M 198M 16.02M 15.67M 688M |
Employees
-
Sector
Pharmaceuticals
